These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34796850)

  • 1. Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation.
    De Lorenzo R; Monno A; Sciorati C; Lorenzetti I; Cavalli S; Bonomi F; Previtali SC; Rovere-Querini P
    Clin Exp Rheumatol; 2022 Feb; 40(2):237-246. PubMed ID: 34796850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies.
    Day JA; Bajic N; Gentili S; Patel S; Limaye V
    Muscle Nerve; 2019 Nov; 60(5):549-557. PubMed ID: 31397909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic inflammatory myopathies: a review.
    Ashton C; Paramalingam S; Stevenson B; Brusch A; Needham M
    Intern Med J; 2021 Jun; 51(6):845-852. PubMed ID: 34155760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.
    Kamperman RG; van der Kooi AJ; de Visser M; Aronica E; Raaphorst J
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
    Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
    Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
    Honda M; Shimizu F; Sato R; Nakamori M
    J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idiopathic inflammatory myopathies. A review].
    Acosta I; Matamala JM; Jara P; Pino F; Gallardo A; Verdugo R
    Rev Med Chil; 2019 Mar; 147(3):342-355. PubMed ID: 31344172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity.
    Mahoudeau A; Anquetil C; Tawara N; Khademian H; Amelin D; Bolko L; Silvestro M; Cin JD; Tendrel B; Tardif V; Mariampillai K; Butler-Browne G; Benveniste O; Allenbach Y
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12849. PubMed ID: 36168256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory muscle disease - An update.
    Baig S; Paik JJ
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients.
    Sun C; Tian X; Yang H; Yang H; Li S; Jiang W; Peng Q; Wang G; Lu X
    Clin Exp Rheumatol; 2024 Feb; 42(2):302-308. PubMed ID: 38488095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis.
    Pinal-Fernandez I; Quintana A; Milisenda JC; Casal-Dominguez M; Muñoz-Braceras S; Derfoul A; Torres-Ruiz J; Pak K; Dell'Orso S; Naz F; Gutierrez-Cruz G; Milone M; Shelly S; Duque-Jaimez Y; Tobias-Baraja E; Matas-Garcia A; Garrabou G; Padrosa J; Ros J; Trallero-Araguás E; Walitt B; Christopher-Stine L; Lloyd TE; Zhao C; Swift S; Rajan A; Grau-Junyent JM; Selva-O'Callaghan A; Liewluck T; Mammen AL
    Ann Rheum Dis; 2023 Jun; 82(6):829-836. PubMed ID: 36801811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum.
    Zierer LK; Naegel S; Schneider I; Kendzierski T; Kleeberg K; Koelsch AK; Scholle L; Schaefer C; Naegel A; Zierz S; Otto M; Stoltenburg-Didinger G; Kraya T; Stoevesandt D; Mensch A
    J Neurol; 2024 Jun; 271(6):3186-3202. PubMed ID: 38438820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of idiopathic inflammatory myopathies: pathology perspectives.
    Tanboon J; Nishino I
    Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
    De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
    Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.